CHMP OK for Santen's Ikervis in severe keratitis
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's CHMP has given Santen's Ikervis (ciclosporin) a positive opinion for severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes.